Adaptive Naming Treatment to Improve Word-Finding in People with Aphasia After Stroke
Balancing Effort and Accuracy in Language Rehabilitation
Led by University of Pittsburgh · Updated on 2026-04-13
30
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Aphasia is a language disorder caused by stroke and other brain injuries that affects many people and impacts their ability to communicate and participate in daily life. This research focuses on anomia, a common difficulty in finding words, and aims to evaluate new treatment approaches that improve long-term retention of naming skills and their use in everyday situations. The study is part of a larger project and specifically investigates balancing effort and accuracy with adaptive speeded naming deadlines.
Participants will receive three different naming treatment conditions in a randomized order an accuracy-maximized condition where the target word is immediately provided, an effort-maximized condition allowing up to 10 seconds to respond before the target is given, and an effort-accuracy balanced condition where deadlines adapt based on individual performance. Each condition consists of eight treatment sessions over four weeks, with treatment time controlled to eight hours per condition. Treatments involve naming pictures with cues and feedback on accuracy.
Participants will be assessed at baseline and followed up one week, three months, and six months after treatment using naming tests, language assessments, and questionnaires on communication effectiveness and motivation. Assessments include confrontation naming of treated and untreated objects, discourse analysis, and communication outcome measures. The study will last about 10 to 18 months per participant, with data collection occurring at the university lab, participants homes, or private public spaces.
CONDITIONS
Brief Title
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
Research Team
A
Alyssa Kelly, M.A., CCC-SLP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Accuracy-maximized naming treatment
Effort-maximized naming treatment
Effort-accuracy balanced naming treatment
What it is
Naming treatment where the correct answer is immediately shown when a picture appears, focusing on repetition and learning accuracy.
Naming treatment where participants have up to 10 seconds to try naming before the correct answer is revealed for repetition, emphasizing patient effort.
Naming treatment where session-by-session time deadlines are set to balance effort and accuracy, recalculating based on individual progress.
Role in trial
One of three crossover therapy conditions tested for effectiveness in improving naming after stroke.
One of three crossover therapy conditions tested for effectiveness in improving naming after stroke.
One of three crossover therapy conditions tested for effectiveness in improving naming after stroke.
Primary use
To help patients with aphasia learn to retrieve words correctly by repeated practice with immediate feedback.
To encourage patients to make their own naming attempts and practice word retrieval by providing time before feedback.
To adapt therapy deadlines session by session, aiming for the best possible balance of patient effort and naming accuracy.
How it is given or performed
Participants see a picture and are immediately given the correct name to repeat.
Participants see a picture and can try naming for up to 10 seconds before the correct answer is given.
Naming deadlines are set dynamically, recalculating each session based on clinician ratings and participant gains.
Evidence status
This condition is being studied in a randomized crossover trial; results are not yet established.
This condition is being studied in a randomized crossover trial; results are not yet established.
This condition is being studied in a randomized crossover trial; results are not yet established.
Important limitations
Effectiveness in real-world communication tasks is unknown until full trial results are published. Immediate feedback may not suit all patients.
There may be variable benefit and challenge for patients with severe impairment who struggle with retrieval. Results are pending.
Session-by-session deadline adjustment requires careful clinician tracking and may be complex for some teams. Overall effectiveness is not yet established.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosis of chronic aphasia lasting more than 6 months after left hemisphere ischemic or hemorrhagic stroke
Impaired performance on at least 2 out of 8 sections of the Comprehensive Aphasia Test
Adults aged 18 years or older
Male or female community-dwelling individuals
You will not qualify if you...
History of other acquired or progressive neurological diseases
Significant impairments in language comprehension
Unmanaged drug or alcohol dependence
Severe diagnosed mood or behavioral disorders requiring specialized mental health treatment
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Treatment
Duration - Approximately 12 weeks (3 conditions, 4 weeks each)
Participants receive three different naming treatment conditions in a randomized order, each consisting of 8 sessions over 4 weeks with 2 sessions per week, focusing on adaptive naming deadlines to improve aphasia.
24 treatment sessions (2 sessions per week for 4 weeks per condition)
Follow-up
Duration - Up to 6 months post-treatment per condition
Participants complete follow-up assessments including probes at 1 week, 3 months, and 6 months after each treatment condition to measure treatment effects and communication changes.
Approximately 3 follow-up assessment sessions per condition
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
6
Similar Trials
Testing Caregiver-Assisted Strategy Training to Improve Daily Activities for Adults After Stroke in a Multi-Center Trial
Study of Brain-Triggered Muscle and Tongue Stimulation to Improve Stroke Recovery in Adults
Digital Treatment Using iPad-Based Training and Coaching to Improve Depression and Cognitive Problems After Stroke in Adults Aged 50 to 79
Smart Home-Based Upper Limb Rehabilitation Using Robot and Task Training for Adults with Stroke and Spinal Cord Injuries
Study of Brain Activity Using Functional Near-Infrared Spectroscopy in Stroke Patients During Mirror Movement
Using a Mobile BrainBody Imaging System to Improve Post-Stroke Walking with a Robotic Device
Study on Intravenous Thrombolysis Using Alteplase or Tenecteplase for Acute Ischemic Stroke Treated Between 4.5 and 24 Hours After Onset
Adaptive Neurofeedback Using Transcranial Magnetic Stimulation and fNIRS to Improve Brain Function After Stroke
Study of StrokeWear Wrist Sensor to Improve Arm Movement in Adults Recovering from Subacute Stroke
Pilot Study of a Community-Based Train-Your-Brain Programme to Improve Cognitive Function and Return-to-Work for Stroke Survivors Aged 21 to 65
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Adaptive balancing of effort, accuracy and response speed in anomia treatment for post-stroke aphasia in community-based settings in the USA: a within-subjects randomised controlled trial protocol.
Candace M van der Stelt, Robert Cavanaugh, William D Hula...